Literature DB >> 3095492

Lipopolysaccharide alteration is associated with induced resistance of Neisseria gonorrhoeae to killing by human serum.

E L Tan, P V Patel, N J Parsons, P M Martin, H Smith.   

Abstract

On SDS-PAGE, solubilized and proteinase K treated preparations of Neisseria gonorrhoeae strain BS4 (agar) showed differences in silver stained lipopolysaccharide (LPS) patterns, before and after induction to resistance to serum killing by incubation for 3 h at 37 degrees C with low Mr fractions from lysates of guinea pig red blood cells. Preparations from the original serum susceptible gonococci and LPS purified from such bacteria showed two components, but the preparations from the serum resistant gonococci were deficient in the higher Mr component. Furthermore, on immunoblotting with fresh human serum (FHS), the two LPS components of the susceptible gonococci reacted strongly with IgM. With preparations from the serum resistant gonococci there was no reaction in the area corresponding to the higher Mr component and a weaker reaction with the component of low Mr. Purified LPS from the susceptible gonococci neutralized the bactericidal activity of FHS against N. gonorrhoeae strain BS4 (agar) probably by reacting with the relevant antibody, since heated FHS was no longer bactericidal when mixed with a source of complement (human placental serum) after prior reaction with the LPS. These neutralization tests coupled with the results of immunoblotting strongly suggest that increased serum resistance is due to the lack of the high Mr LPS moiety.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3095492     DOI: 10.1099/00221287-132-5-1407

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  15 in total

1.  Gonococci in vivo: Host CMP-NANA, sialylated lipopolysaccharide and serum resistance.

Authors:  H Smith
Journal:  Can J Infect Dis       Date:  1993-01

2.  Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera.

Authors:  L M Wetzler; K Barry; M S Blake; E C Gotschlich
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

Review 3.  Molecular basis for serum resistance in Neisseria gonorrhoeae.

Authors:  P A Rice
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

4.  Gonococci in vivo and in vitro. Further studies on the host and bacterial determinants of gonococcal resistance to killing by human serum, and by phagocytes.

Authors:  N J Parsons; P V Patel; P M Martin; E L Tan; C A Nairn; M Goldner; K A Brogden; H Smith
Journal:  Antonie Van Leeuwenhoek       Date:  1987       Impact factor: 2.271

5.  Anaerobic growth and cytidine 5'-monophospho-N-acetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae.

Authors:  J V Frangipane; R F Rest
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

6.  Use of xylE fusions to demonstrate that lsi-1, a Neisseria gonorrhoeae lipooligosaccharide biosynthetic gene, and lsi-3 are not transcriptionally linked.

Authors:  R J Danaher; E F Petricoin; D C Stein
Journal:  J Bacteriol       Date:  1994-06       Impact factor: 3.490

7.  Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils.

Authors:  R F Rest; J V Frangipane
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing.

Authors:  Lisa A Lewis; William M Shafer; Tathagat Dutta Ray; Sanjay Ram; Peter A Rice
Journal:  Infect Immun       Date:  2012-10-15       Impact factor: 3.441

9.  Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry.

Authors:  B W Gibson; W Melaugh; N J Phillips; M A Apicella; A A Campagnari; J M Griffiss
Journal:  J Bacteriol       Date:  1993-05       Impact factor: 3.490

10.  Heparin protects Opa+ Neisseria gonorrhoeae from the bactericidal action of normal human serum.

Authors:  T Chen; J Swanson; J Wilson; R J Belland
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.